Melasma: A comprehensive update : Part I - 14/09/11
Doi : 10.1016/j.jaad.2010.12.046
Vaneeta M. Sheth, MD a, Amit G. Pandya, MD b, ⁎ 
a Department of Dermatology at Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas
Correspondence to: Amit G. Pandya, MD, Department of Dermatology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9190.Abstract |
Melasma is a common disorder of hyperpigmentation affecting millions of people worldwide. While it is thought to be triggered or exacerbated by sun exposure and hormones, much remains to be understood about its pathogenesis. A thorough understanding of the etiology of melasma and the research tools available to study this condition are crucial to enhancing management and developing novel targeted therapies of this often frustrating condition.
Il testo completo di questo articolo è disponibile in PDF.Key Words : chemical peels, chloasma, hydroquinone, laser therapy, melasma, pigmentation
Mappa
| Funding sources: None. |
|
| Reprints not available from the authors. |
© 2010
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 65 - N° 4
P. 689-697 - ottobre 2011 Ritorno al numero
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?